Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Hinge Health, Inc.HNGE · Entity 377 | Director | September 14, 2026 | September 16, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Hinge Health, Inc.
Report date September 14, 2026 · Filed September 16, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | IndirectSee footnote | 0 |
Reported balance
After 2026-09-14 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2026-09-14 · Sale · Disposed 0 · Balance 0 F1: On September 14, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 76,306 and 71,632 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.53. These shares were sold in multiple transactions at prices ranging from $92.71 to $93.64. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: On September 14, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 76,306 and 71,632 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.53. These shares were sold in multiple transactions at prices ranging from $92.71 to $93.64. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
F2: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 14, 2026 Filed Sep 16, 2026 21:47 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-393293 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On September 14, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 76,306 and 71,632 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.53. These shares were sold in multiple transactions at prices ranging from $92.71 to $93.64. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On September 14, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 76,306 and 71,632 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.53. These shares were sold in multiple transactions at prices ranging from $92.71 to $93.64. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 09, 2026 Filed Sep 11, 2026 22:50 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-389521 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On September 9, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 5,489 and 5,848 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.37. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.69. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On September 9, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 5,489 and 5,848 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.37. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.69. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 08, 2026 Filed Sep 9, 2026 21:50 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-386693 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · shares: On September 8, 2026, BVP X and BVP X Inst sold 21,006 and 19,719 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.58. These shares were sold in multiple transactions at prices ranging from $92.00 to $93.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On September 8, 2026, BVP X and BVP X Inst sold 21,006 and 19,719 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.58. These shares were sold in multiple transactions at prices ranging from $92.00 to $93.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 04, 2026 Filed Sep 9, 2026 21:50 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-386693 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On September 4, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 7,450 and 6,994 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.17. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.73. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On September 4, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 7,450 and 6,994 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.17. These shares were sold in multiple transactions at prices ranging from $92.00 to $92.73. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| September 03, 2026 Filed Sep 4, 2026 22:14 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-383894 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On September 2, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 35,918 and 33,717 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.01. These shares were sold in multiple transactions at prices ranging from $92.72 to $93.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. F3 · ownership.nature: On September 3, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 516 and 484 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $92.64. These shares were sold in multiple transactions at prices ranging from $92.05 to $92.99. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| September 02, 2026 Filed Sep 4, 2026 22:14 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-383894 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On September 2, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 35,918 and 33,717 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.01. These shares were sold in multiple transactions at prices ranging from $92.72 to $93.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On September 2, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 35,918 and 33,717 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $93.01. These shares were sold in multiple transactions at prices ranging from $92.72 to $93.52. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| August 26, 2026 Filed Aug 27, 2026 21:15 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-371548 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. F3 · ownership.nature: On August 26, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 58,484 and 55,243 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.71. These shares were sold in multiple transactions at prices ranging from $91.20 to $92.07. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| August 25, 2026 Filed Aug 27, 2026 21:15 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-371548 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On August 25, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 115,202 and 108,144 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $91.08. These shares were sold in multiple transactions at prices ranging from $90.50 to $91.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| August 19, 2026 Filed Aug 21, 2026 21:19 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-361316 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On August 19, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 13,527 and 12,699 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $90.05. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On August 19, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 13,527 and 12,699 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $90.05. These shares were sold in multiple transactions at prices ranging from $90.00 to $90.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 12, 2026 Filed Jun 12, 2026 20:18 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269490 · ownership.xml · nonDerivative · entry 3 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On June 10, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 15,619 and 14,662 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.20. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. F4 · ownership.nature: On June 12, 2026, BVP X and BVP X Inst sold 8,694 and 8,161 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.24. These shares were sold in multiple transactions at prices ranging from $65.00 to $66.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 11, 2026 Filed Jun 12, 2026 20:18 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269490 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On June 10, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 15,619 and 14,662 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.20. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On June 11, 2026, BVP X and BVP X Inst sold 30,042 and 28,201 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $66.02. These shares were sold in multiple transactions at prices ranging from $65.55 to $66.45. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 10, 2026 Filed Jun 12, 2026 20:18 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-269490 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On June 10, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 15,619 and 14,662 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.20. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On June 10, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 15,619 and 14,662 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $65.20. These shares were sold in multiple transactions at prices ranging from $65.00 to $65.88. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 02, 2026 Filed Jun 3, 2026 21:31 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-255819 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On June 1, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 51,580 and 48,420 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $61.08. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On June 2, 2026, BVP X and BVP X Inst sold 10,121 and 9,500 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $60.34. These shares were sold in multiple transactions at prices ranging from $60.00 to $60.74. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| June 01, 2026 Filed Jun 3, 2026 21:31 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-255819 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On June 1, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 51,580 and 48,420 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $61.08. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On June 1, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 51,580 and 48,420 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $61.08. These shares were sold in multiple transactions at prices ranging from $60.82 to $61.44. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 08, 2026 Filed May 12, 2026 00:22 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-217560 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On May 7, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 154,740 and 145,260 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $54.77. These shares were sold in multiple transactions at prices ranging from $54.10 to $55.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On May 8, 2026, BVP X and BVP X Inst sold 103,160 and 96,840 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $55.16. These shares were sold in multiple transactions at prices ranging from $55.04 to $56.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| May 07, 2026 Filed May 12, 2026 00:22 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-217560 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On May 7, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 154,740 and 145,260 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $54.77. These shares were sold in multiple transactions at prices ranging from $54.10 to $55.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On May 7, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 154,740 and 145,260 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $54.77. These shares were sold in multiple transactions at prices ranging from $54.10 to $55.00. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 00:12 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-059889 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On February 17, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 46,276 and 43,440 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $39.929. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On February 18, 2026, BVP X and BVP X Inst sold 48,353 and 45,390 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.358. These shares were sold in multiple transactions at prices ranging from $39.535 to $40.855. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| February 17, 2026 Filed Feb 20, 2026 00:12 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-059889 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On February 17, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 46,276 and 43,440 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $39.929. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On February 17, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 46,276 and 43,440 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $39.929. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.31. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| February 13, 2026 Filed Feb 17, 2026 21:15 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054667 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On February 12, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 12,086 and 11,346 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.096. These shares were sold in multiple transactions at prices ranging from $40.025 to $40.115. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On February 13, 2026, BVP X and BVP X Inst sold 77,328 and 72,591 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.109. These shares were sold in multiple transactions at prices ranging from $39.50 to $40.722. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| February 12, 2026 Filed Feb 17, 2026 21:15 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-054667 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On February 12, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 12,086 and 11,346 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.096. These shares were sold in multiple transactions at prices ranging from $40.025 to $40.115. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On February 12, 2026, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 12,086 and 11,346 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $40.096. These shares were sold in multiple transactions at prices ranging from $40.025 to $40.115. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| December 05, 2025 Filed Dec 9, 2025 21:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-312853 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On December 5, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 2,614 and 2,453 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.0166. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On December 5, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 2,614 and 2,453 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.0166. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.12. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 00:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-304228 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · shares: On November 28, 2025, BVP X and BVP X Inst sold 23,176 and 21,757 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.1555. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F2 · ownership.nature: On November 28, 2025, BVP X and BVP X Inst sold 23,176 and 21,757 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.1555. These shares were sold in multiple transactions at prices ranging from $50.00 to $50.53. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| November 26, 2025 Filed Dec 2, 2025 00:37 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-304228 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F1 · shares: On November 26, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 103,160 and 96,840 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.5040. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F1 · ownership.nature: On November 26, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") sold 103,160 and 96,840 shares of Class A Common Stock of the Issuer, respectively, at a weighted average price of $50.5040. These shares were sold in multiple transactions at prices ranging from $50.00 to $51.35. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 23:54 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass B Common Stock · Derivative | 0 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-290163 · ownership.xml · derivative · entry 3 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Underlying: Class A Common Stock · 0 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · price: On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.exercise_date: On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · derivative.expiration_date: On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 23:54 UTC | Hinge Health, Inc. HNGE · Entity 377 | SaleClass A Common Stock | 0 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-290163 · ownership.xml · nonDerivative · entry 2 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · shares: BVP X sold 373,955 shares of Class A Common Stock of the Issuer, and BVP X Inst. sold 351,045 shares of Class A Common Stock of the Issuer. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
| November 18, 2025 Filed Nov 20, 2025 23:54 UTC | Hinge Health, Inc. HNGE · Entity 377 | ConversionClass A Common Stock | 0 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-25-290163 · ownership.xml · nonDerivative · entry 1 Robinson Elliott · CIK 0002058536 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F1 · ownership.nature: On November 18, 2025, Bessemer Venture Partners X L.P. ("BVP X") and Bessemer Venture Partners X Institutional L.P. ("BVP X Inst") (together with BVP X, the "Bessemer Funds") converted 2,119,271 and 1,989,436 shares of Class B Common Stock of the Issuer, respectively, into 2,119,271 and 1,989,436 shares of Class A Common Stock of the issuer, respectively. The Class B Common Stock was convertible into shares of Class A Common Stock upon the occurrence of certain events as described further in the Issuer's amended and restated certificate of incorporation. F3 · ownership.nature: The Reporting Person is a partner at Bessemer Venture Partners and has an indirect, passive economic interest in the shares held by the Bessemer Funds by virtue of his interest in (1) Deer X & Co. L.P., the general partner of the Bessemer Funds and (2) certain other indirect limited partnership interests in certain of the Bessemer Funds. The Reporting Person disclaims beneficial ownership of the securities held by the Bessemer Funds, except to the extent of his pecuniary interest, if any, in such securities by virtue of his indirect interest in the Bessemer Funds. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.